Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes [Phase 2, Phase 3]
A Phase 2/Phase 3 study assessing the effects of caffeine and chlorogenic acid supplementation on inflammatory, metabolic factors, hepatic s…
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM) [Phase 4]
A Phase 4 real-world study (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM) evaluating efficacy and health outcomes of Toujeo for Type 2 diabetes; …
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics [NA]
A completed clinical trial investigating continuous glucose monitors to regulate glucose levels in individuals with Type 2 diabetes; results…
-
CLINICAL_TRIALS trial_result · 2019-04-30Clinical Trial Update: A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes [Phase 4]
Phase 4 trial evaluating glucodynamic effects of dulaglutide (LY2189265) in Japanese participants with type 2 diabetes has completed and pos…
-
CLINICAL_TRIALS research · 2019-04-24Clinical Trial Update: Impact of P53 and SIRT1 in Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial updating on the role of P53 and SIRT1 in type 2 diabetes is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-04-23FDA Approved: GLIPIZIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for glipizide filed by Rising Pharma Holdings, Inc. under ANDA 204720.
-
CLINICAL_TRIALS trial_result · 2019-04-19Clinical Trial Update: Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice
Non-interventional study evaluating alogliptin and alogliptin fixed-dose combinations with pioglitazone or metformin in standard clinical pr…
-
FDA approval · 2019-04-19FDA Approved: NATEGLINIDE — Original Application (Modavar Pharmaceuticals LLC)
FDA approved the original application for a generic Nateglinide product from Modavar Pharmaceuticals LLC. It is used to improve glycemic con…
-
FDA approval · 2019-04-17FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Metformin Hydrochloride from Macleods Pharmaceuticals Limited (ANDA206955), typically involv…
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Interventional Study of Active Weight Management in Patients With Type 2 Diabetes and Obesity in Routine Clinical Practice During 12 Months. [Phase 4]
Phase 4 interventional study on active weight management in routine practice for patients with type 2 diabetes and obesity; study completed …
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2 [Phase 4]
Phase 4 trial evaluating blood glucose response after ingesting lactulose in patients with type 2 diabetes and mild constipation; study comp…
-
FDA approval · 2019-04-10FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc. This action const…
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM [NA]
A completed clinical trial evaluated a telephone-delivered behavioral skills intervention for Black adults with Type 2 diabetes mellitus; re…
-
FDA approval · 2019-04-09FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for OZEMPIC (semaglutide) from Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus [Phase 1, Phase 2]
A phase 1/2 multiple-ascending-dose trial evaluating MEDI0382 in overweight/obese adults with type 2 diabetes mellitus, focusing on efficacy…
-
CLINICAL_TRIALS trial_result · 2019-04-04Clinical Trial Update: Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism [Phase 4]
A Phase 4 clinical trial investigating the effect of testosterone on endothelial function and microcirculation in men with type 2 diabetes a…
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 trial evaluating the effects of vildagliptin and metformin in patients with type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002) [Phase 1]
Phase 1 multiple ascending dose study of MK-5160 in adults with Type 1 and Type 2 diabetes completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes [Phase 2]
Phase 2 clinical trial evaluating ETC 1002 for efficacy and safety in subjects with Type 2 Diabetes; study completed.
-
CLINICAL_TRIALS trial_result · 2019-03-27Clinical Trial Update: The Effect of Biscuit Containing Kothala Himbutu on Blood Glucose in Patients With Diabetes. A Randomized Control Study [Phase 3]
Phase 3 randomized trial evaluating a biscuit containing Kothala Himbutu on blood glucose in patients with Type 2 Diabetes Mellitus; study c…
-
CLINICAL_TRIALS trial_result · 2019-03-27Clinical Trial Update: Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 clinical trial evaluating empagliflozin added to insulin in Japanese patients with type 2 diabetes completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea [Phase 4]
Phase 4 trial evaluating efficacy and safety of dapagliflozin alone and with saxagliptin plus metformin versus sulphonylurea in type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2019-03-25Clinical Trial Update: Promoting the Universal Medication Schedule Via Mobile and EHR Technologies [NA]
Clinical trial update focused on promoting the Universal Medication Schedule through mobile and EHR technologies, completed with results pos…
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: Glucocorticoids and Skin Healing in Diabetes (GC-SHealD) [Phase 2]
Phase 2 trial investigating glucocorticoids for skin healing in type 2 diabetes completed.
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: A Single-dose Trial to Investigate the Safety and Tolerability of XEN-D0501 in Patients With Diabetes Mellitus Type 2 [Phase 2]
Phase 2 single-dose study assessing safety and tolerability of XEN-D0501 in adults with Type 2 diabetes; study completed.